Corbus Pharmaceuticals Holdings Inc Intrinsic Valuation and Fundamental Analysis - Corbus Pharmaceuticals Holdings Inc

C	Corbus Pharmaceuticals Holdings Inc F:337	US
A	Allcore SpA MIL:CORE	IT
I	Internet Thailand PCL SET:INET	TH

Intrinsic Value

337 doesn't have a meaningful market cap.

The intrinsic value for Corbus Pharmaceuticals Holdings Inc (337) under the Base Case is 0.339 EUR. Compared with the current market price of 4.338 EUR, the stock appears Overvalued by 92% .

Intrinsic value calculated using Multiples

€0.339

Other reference points

Wall St target

€18.519

Do our valuations actually work? See backtest results .

Intrinsic Value

Overvaluation 92%

Intrinsic Value

Price €4.338

Track Buy Zone

20% below Intrinsic Value €0.27

Get notified when the price drops into your buy zone

Current Price €4.34

Intrinsic Value €0.34

Margin of Safety 20% €0.27

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Corbus Pharmaceuticals Holdings Inc.

Explain Valuation